Outcomes for oligometastatic head and neck cancer treated with stereotactic body radiotherapy: Results from an international multi-institutional consortium

被引:2
|
作者
Said, Badr Id [1 ]
Mutsaers, Adam [1 ]
Chen, Hanbo [1 ]
Husain, Zain A. [1 ]
Biswas, Tithi [2 ]
Dagan, Roi [3 ]
Erler, Darby [1 ]
Foote, Matthew [4 ]
Louie, Alexander V. [1 ]
Redmond, Kristin [5 ]
Ricardi, Umberto [6 ]
Sahgal, Arjun [1 ]
Poon, Ian [1 ,7 ]
机构
[1] Sunnybrook Hlth Sci Ctr, Odette Canc Ctr, Dept Radiat Oncol, Toronto, ON, Canada
[2] Univ Hosp Seidman Canc Ctr, Dept Radiat Oncol, Cleveland, OH USA
[3] Univ Florida, Hlth Proton Therapy Inst, Jacksonville, FL USA
[4] Univ Queensland, Princess Alexandra Hosp, Dept Radiat Oncol, Brisbane, Qld, Australia
[5] Johns Hopkins Univ, Dept Radiat Oncol & Mol Radiat Sci, Sch Med, Baltimore, MD USA
[6] Univ Turin, Dept Oncol, Turin, Italy
[7] Sunnybrook Hlth Sci Ctr, Odette Canc Ctr, 2075 Bayview Ave,T2 181, Toronto, ON M4N 3M5, Canada
关键词
oligometastatic; head and neck cancer; radiation oncology; SABR; SBRT; SQUAMOUS-CELL CARCINOMA; RADIATION-THERAPY; PULMONARY METASTASES; TRIAL; LUNG; MULTICENTER; RESECTION; ASTRO;
D O I
10.1002/hed.27488
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
BackgroundWe report the results of an international multi-institutional cohort of oligometastatic (OMD) head and neck cancer (HNC) patients treated with SBRT. MethodsPatients with OMD HNC (& LE;5 metastases) treated with SBRT between 2008 and 2016 at six institutions were included. Treated metastasis control (TMC), progression-free survival (PFS), and overall survival (OS) were analyzed by multivariable analysis (MVA). ResultsForty-two patients with 84 HNC oligometastases were analyzed. The TMC rate at 1 and 2 years were 80% and 66%, with a median time to recurrence of 10.1 months. The median PFS and OS were 4.7 and 23.3 months. MVA identified a PTV point maximum (BED)10 > 100 Gy as a predictor of improved TMC (HR = 0.31, p = 0.034), and a cumulative PTV > 48 cc as having worse PFS (HR = 2.99, p < 0.001). ConclusionFavorable TMC and OS was observed in OMD HNCs treated with SBRT.
引用
收藏
页码:2627 / 2637
页数:11
相关论文
共 50 条
  • [21] Stereotactic body radiotherapy and tyrosine kinase inhibitors in patients with oligometastatic renal cell carcinoma: a multi-institutional study
    Onal, Cem
    Oymak, Ezgi
    Guler, Ozan Cem
    Tilki, Burak
    Yavas, Guler
    Hurmuz, Pervin
    Yavas, Cagdas
    Ozyigit, Gokhan
    [J]. STRAHLENTHERAPIE UND ONKOLOGIE, 2023, 199 (05) : 456 - 464
  • [22] Outcomes of Oligometastatic Colorectal Cancer treated with Stereotactic Ablative Radiotherapy
    Benson, K.
    Sandhu, N.
    Zhang, C.
    Ko, R. B.
    Toesca, D. A. S.
    Von Eyben, R.
    Diehn, M.
    Bush, K.
    Maxim, P. G.
    Gensheimer, M. F.
    Soltys, S. G.
    Loo, B. W., Jr.
    Pollom, E.
    Chang, D. T.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E161 - E162
  • [23] Multi-institutional Analysis of Solitary Extramedullary Plasmacytoma of the Head and Neck Treated with Curative Radiotherapy
    Sasaki, R.
    Kawabe, T.
    Abe, E.
    Uchida, N.
    Yasuda, K.
    Uno, T.
    Fujiwara, M.
    Shioyama, Y.
    Shibamoto, Y.
    Yamada, S.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (03): : S419 - S420
  • [24] MULTI-INSTITUTIONAL ANALYSIS OF SOLITARY EXTRAMEDULLARY PLASMACYTOMA OF THE HEAD AND NECK TREATED WITH CURATIVE RADIOTHERAPY
    Sasaki, Ryohei
    Yasuda, Koichi
    Abe, Eisuke
    Uchida, Nobue
    Kawashima, Mitsuhiko
    Uno, Takashi
    Fujiwara, Masayuki
    Shioyama, Yoshiyuki
    Kagami, Yoshikazu
    Shibamoto, Yuta
    Nakata, Kensei
    Takada, Yoshie
    Kawabe, Tetsuya
    Uehara, Kazuyuki
    Nibu, Kenichi
    Yamada, Syogo
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 82 (02): : 626 - 634
  • [25] Lung stereotactic ablative body radiotherapy: A large scale multi-institutional planning comparison for interpreting results of multi-institutional studies
    Giglioli, Francesca Romana
    Strigari, Lidia
    Ragona, Riccardo
    Borzi, Giuseppina R.
    Cagni, Elisabetta
    Carbonini, Claudia
    Clemente, Stefania
    Consorti, Rita
    El Gawhary, Randa
    Esposito, Marco
    Falco, Maria Daniela
    Fedele, David
    Fiandra, Christian
    Frassanito, Maria Cristina
    Landoni, Valeria
    Loi, Gianfranco
    Lorenzini, Elena
    Malisan, Maria Rosa
    Marino, Carmelo
    Menghi, Enrico
    Nardiello, Barbara
    Nigro, Roberta
    Oliviero, Caterina
    Pastore, Gabriella
    Quattrocchi, Mariagrazia
    Ruggieri, Ruggero
    Redaelli, Irene
    Reggiori, Giacomo
    Russo, Serenella
    Villaggi, Elena
    Casati, Marta
    Mancosu, Pietro
    [J]. PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS, 2016, 32 (04): : 600 - 606
  • [26] Stereotactic body radiotherapy and tyrosine kinase inhibitors in patients with oligometastatic renal cell carcinoma: a multi-institutional study
    Cem Onal
    Ezgi Oymak
    Ozan Cem Guler
    Burak Tilki
    Guler Yavas
    Pervin Hurmuz
    Cagdas Yavas
    Gokhan Ozyigit
    [J]. Strahlentherapie und Onkologie, 2023, 199 : 456 - 464
  • [27] Clinical Outcomes of Stereotactic Body Radiotherapy in Oligometastatic Gynecological Cancer
    Laliscia, Concetta
    Fabrini, Maria Grazia
    Delishaj, Durim
    Morganti, Riccardo
    Greco, Carlo
    Cantarella, Martina
    Tana, Roberta
    Paiar, Fabiola
    Gadducci, Angiolo
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 (02) : 396 - 402
  • [28] Multi-institutional analysis of high-risk prostate cancer patients treated with stereotactic body radiotherapy.
    Jiang, Naomi Y.
    King, Christopher R.
    Katz, Alan J.
    Collins, Sean P.
    Aghdam, Nima
    Suy, Simeng
    Stephans, Kevin L.
    Reddy, Chandana A.
    Kaplan, Irving D.
    Appelbaum, Limor
    Dang, Audrey
    Yuan, Ye
    Nickols, Nicholas George
    Steinberg, Michael L.
    Kupelian, Patrick
    Kishan, Amar Upadhyaya
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
  • [29] An analysis of a large multi-institutional database reveals important associations between treatment parameters and clinical outcomes for stereotactic body radiotherapy (SBRT) of oligometastatic colorectal cancer
    Sheikh, Saad
    Chen, Hanbo
    Sahgal, Arjun
    Poon, Ian
    Erler, Darby
    Badellino, Serena
    Dagan, Roi
    Foote, Matthew C.
    Louie, Alexander, V
    Redmond, Kristin J.
    Ricardi, Umberto
    Biswas, Tithi
    [J]. RADIOTHERAPY AND ONCOLOGY, 2022, 167 : 187 - 194
  • [30] A multi-institutional analysis of outcomes following stereotactic body radiation therapy for management of metastases from squamous cell carcinomas of the head and neck
    Singh, Raj
    Jenkins, Jan
    Davis, Joanne
    Song, Shiyu
    Sharma, Sanjeev
    Vargo, John Austin
    [J]. JOURNAL OF RADIOSURGERY AND SBRT, 2022, 8 (01): : 11 - 19